2 results
Approved WMOCompleted
Primary Objectives* To compare the pathologic complete response (pCR) rate of neoadjuvant nivolumab + NKTR-214 to Standard of Care (SOC, no neoadjuvant therapy) in all randomized participants* To compare the event-free survival (EFS) of neoadjuvant…
Approved WMORecruiting
The project*s overarching aim is to diminish respiratory disease burden in moderate-late preterm born infants in their first year of life.We have formulated the following specific aims: 1. Determine whether bacterial lysates reduce the number and/or…